For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
New legislation seeks to shuffle the deck chairs on the sinking No Surprises Act
On October 8, Rep. Frank Pallone (D-NJ) introduced the Lower Premiums, Faster Payments Act as a fix for the disastrous No Surprises Act (NSA).
Search Posts
Blog
Misconceptions about the Obama Administration’s Contraception Mandate for Religious Employers
There are a number of misconceptions about the Obama administration’s recent rule requiring employers’ health insurance policies (including those of religious schools and hospitals) to…
Blog
Government Thwarts Cancer Cures and Production of Life-Saving Drugs
The federal government thwarted a promising cancer treatment. The Food and Drug Administration (FDA) put Dr. Stanislaw Burzynski on trial twice, saying “it did…
Citation
Vincent Vernuccio explains the union’s latest method of recruitment.
Vincent Vernuccio explains the union's the latest method of forcing home healthcare and daycare workers into their unions…
Citation
Seeking Solution to “Incredibly Complex” Issue of Drug Shortages
Blog
CEI Podcast for February 2, 2012: The FDA’s Latest Power Grab
Fellow in Consumer Policy Studies Michelle Minton breaks down the FDA's behind-the-scenes push to regulate dietary supplements nearly as strictly as prescription drugs.
Blog
Justice Kagan Should Recuse Herself from Obamacare Case
Only in Bizarro World can you claim someone is your attorney -- and thus shielded by attorney work-product privilege -- and then insist in the…